172 related articles for article (PubMed ID: 6437866)
21. Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release.
Gourdji D; Bataille D; Vauclin N; Grouselle D; Rosselin G; Tixier-Vidal A
FEBS Lett; 1979 Aug; 104(1):165-8. PubMed ID: 89971
[No Abstract] [Full Text] [Related]
22. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
[TBL] [Abstract][Full Text] [Related]
23. Prolactin release from MtTW15 and 7315a pituitary tumors is refractory to TRH and VIP stimulation.
Judd AM; Canonico PL; MacLeod RM
Mol Cell Endocrinol; 1984 Jul; 36(3):221-8. PubMed ID: 6088325
[TBL] [Abstract][Full Text] [Related]
24. Effects of repeated stimuli on prolactin release in vitro from normal and adenomatous rat lactotrophs.
Lafond J; Collu R
Mol Cell Endocrinol; 1986 Sep; 47(1-2):175-81. PubMed ID: 3091427
[TBL] [Abstract][Full Text] [Related]
25. The effects of dopaminergic antagonism by sulpiride on TRH and VIP-induced prolactin release in nonsuckled lactating rats.
Haisenleder DJ; Moy JA; Lawson DM
Life Sci; 1990; 46(25):1867-72. PubMed ID: 2163481
[TBL] [Abstract][Full Text] [Related]
26. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
Pu HF; Liu TC
J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
[TBL] [Abstract][Full Text] [Related]
27. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
[TBL] [Abstract][Full Text] [Related]
28. 31P-Nuclear magnetic resonance spectroscopy of rat pituitary tumours in vivo.
Prysor-Jones RA; Silverlight JJ; Jenkins JS; Stevens AN; Rodrigues JL; Griffiths JR
J Endocrinol; 1985 Sep; 106(3):349-53. PubMed ID: 4045341
[TBL] [Abstract][Full Text] [Related]
29. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone.
Martinez de la Escalera G; Weiner RI
Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665
[TBL] [Abstract][Full Text] [Related]
30. Melatonin reduces the production and secretion of prolactin and growth hormone from rat pituitary cells in culture.
Griffiths D; Bjøro T; Gautvik K; Haug E
Acta Physiol Scand; 1987 Sep; 131(1):43-9. PubMed ID: 2823532
[TBL] [Abstract][Full Text] [Related]
31. Role of ionotropic glutamate receptors in the control of prolactin secretion by other neurotransmitters and neuropeptides at the level of the pituitary.
Jain SK; Zelena D
Endocr Regul; 2013 Apr; 47(2):65-74. PubMed ID: 23641787
[TBL] [Abstract][Full Text] [Related]
32. Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.
Maas DL; Arnaout MA; Martinson DR; Erdmann MD; Hagen TC
Endocrinology; 1991 Feb; 128(2):1015-20. PubMed ID: 1899215
[TBL] [Abstract][Full Text] [Related]
33. Requirement of oestrogens for the sensitivity of prolactin cells to vasoactive intestinal peptide in rats and man.
Pizzi M; Rubessa S; Simonazzi E; Zanagnolo V; Falsetti L; Memo M; Spano PF
J Endocrinol; 1992 Feb; 132(2):311-6. PubMed ID: 1541929
[TBL] [Abstract][Full Text] [Related]
34. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
Martínez de la Escalera G; Guthrie J; Weiner RI
Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of growth hormone release by vasoactive intestinal peptide and peptide PHI in rat anterior pituitary reaggregates. Permissive action of a glucocorticoid and inhibition by thyrotropin-releasing hormone.
Denef C; Schramme C; Baes M
Neuroendocrinology; 1985 Jan; 40(1):88-91. PubMed ID: 3918279
[TBL] [Abstract][Full Text] [Related]
37. Thyrotrophin releasing hormone-induced growth hormone and prolactin release: physiological studies in intact rats and in hypophysectomized rats bearing an ectopic pituitary gland.
Panerai AE; Gil-Ad I; Cocchi D; Locatelli V; Rossi GL; Müller EE
J Endocrinol; 1977 Mar; 72(3):301-11. PubMed ID: 404376
[TBL] [Abstract][Full Text] [Related]
38. Basal and TRH-stimulated prolactin in patients with pituitary tumours.
Lamberts SW; Birkenhäger JC; Kwa HG
Clin Endocrinol (Oxf); 1976 Nov; 5(6):709-11. PubMed ID: 827399
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
Shah GV; Wang W; Grosvenor CE; Crowley WR
Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
[TBL] [Abstract][Full Text] [Related]
40. [Characterization of the stimulant effect of 2 neuropeptides (thyroliberin (TRH) and vasoactive intestinal peptide (VIP)) on the secretion of the growth hormone in the rat].
Durand D; Bluet-Pajot MT; Mounier F; Leonard JF; Pressac M
Reprod Nutr Dev (1980); 1987; 27(2B):481-9. PubMed ID: 3114836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
